《大行報告》星展對內地科網股投資評級及目標價(表)
星展發表研究報告,列出對內地科網股最新投資評級及目標價,表列如下:
股份 | 投資評級 | 目標價
阿里巴巴-SW(09988.HK) | 買入 | 162港元
百度集團-SW(09888.HK) | 買入 | 174港元
京東集團-SW(09618.HK) | 買入 | 234港元
美團-W(03690.HK) | 買入 | 230港元
網易-S(09999.HK) | 買入 | 240港元
拼多多(PDD.US) | 買入 | 154美元
騰訊控股(00700.HK) | 買入 | 498港元
同程旅行(00780.HK) | 買入 | 29港元
攜程集團-S(9961.HK) | 買入 | 445港元
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.